|
|
Volumn 130, Issue 3, 2013, Pages 192-195
|
|
Treating chronic myeloid leukemia in the era of tyrosine kinase inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
BOSUTINIB;
DASATINIB;
IMATINIB;
NILOTINIB;
PONATINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
DIARRHEA;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
GENE MUTATION;
HEADACHE;
HUMAN;
LIVER DYSFUNCTION;
MEDICAL INFORMATION;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
PLEURA EFFUSION;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PULMONARY HYPERTENSION;
RASH;
REVIEW;
STEM CELL;
TREATMENT RESPONSE;
|
|
EID: 84878943710
PISSN: 00015792
EISSN: 14219662
Source Type: Journal
DOI: 10.1159/000351957 Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|
